Fig. 1
From: Prognostic marker CD27 and its micro-environmental in multiple myeloma
The expression level of CD27 in MM patients with different clinical characteristics. A, B CD27 expression level in different subtypes of myeloma patients in GSE5900 and GSE6477. C The expression level of CD27 in different recurrence states of MM in GSE31161. D Comparison of CD27 expression levels between ISS I/II and ISS III phases in GSE136337. E, F Expression of CD27 in different survival subgroups (EFS24m and OS24m) in GSE24080. * P < 0.05, ** P < 0.01, *** P < 0.001 and **** P < 0.0001